Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1166.45
-9.10 (-0.77%)
< Home < Back

Dr Reddy's Laboratories reply to clarification sought by exchange

Date: 05-04-2022

Dr Reddy's Laboratories has informed that the Exchange had sought clarification with respect to news article appearing on https://economictimes.indiatimes.com dated March 31, 2022 titled ‘Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance’. Dr Reddys Laboratory’s response is enclosed.

The above information is a part of company’s filings submitted to BSE.